Yao Liu1, Rebecca Swearingen2. 1. Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, 2870 University Ave, Ste 206, Madison, WI, 53705, USA. Liu463@wisc.edu. 2. Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, 2870 University Ave, Ste 206, Madison, WI, 53705, USA.
Abstract
PURPOSE OF REVIEW: Diabetic retinopathy remains the leading cause of blindness among working-age US adults even though timely screening and treatment prevent 90% of blindness. We summarize current knowledge and perspectives to better understand why diabetic eye screening rates remain low and future directions towards preventing blindness from diabetes. RECENT FINDINGS: Significant advancements in the past 10 years include primary care and patient-oriented interventions as well as the use of teleophthalmology. In England, diabetic eye disease is no longer the leading cause of certifiable blindness following the implementation of a national teleophthalmology program for diabetic retinopathy. Multiple workflow and systems-level barriers affect providers. Patient barriers include a limited understanding of screening and lack of access to care. Interventions have been developed, but new barriers exist towards sustaining their impact. More research is needed to identify and implement the best practices to increase diabetic eye screening rates long-term.
PURPOSE OF REVIEW: Diabetic retinopathy remains the leading cause of blindness among working-age US adults even though timely screening and treatment prevent 90% of blindness. We summarize current knowledge and perspectives to better understand why diabetic eye screening rates remain low and future directions towards preventing blindness from diabetes. RECENT FINDINGS: Significant advancements in the past 10 years include primary care and patient-oriented interventions as well as the use of teleophthalmology. In England, diabetic eye disease is no longer the leading cause of certifiable blindness following the implementation of a national teleophthalmology program for diabetic retinopathy. Multiple workflow and systems-level barriers affect providers. Patient barriers include a limited understanding of screening and lack of access to care. Interventions have been developed, but new barriers exist towards sustaining their impact. More research is needed to identify and implement the best practices to increase diabetic eye screening rates long-term.
Authors: Kimberly S H Yarnall; Kathryn I Pollak; Truls Østbye; Katrina M Krause; J Lloyd Michener Journal: Am J Public Health Date: 2003-04 Impact factor: 9.308
Authors: John D Whited; Santanu K Datta; Lloyd M Aiello; Lloyd P Aiello; Jerry D Cavallerano; Paul R Conlin; Mark B Horton; Robert A Vigersky; Ronald K Poropatich; Pratap Challa; Adam W Darkins; Sven-Erik Bursell Journal: Telemed J E Health Date: 2005-12 Impact factor: 3.536
Authors: Truls Østbye; Kimberly S H Yarnall; Katrina M Krause; Kathryn I Pollak; Margaret Gradison; J Lloyd Michener Journal: Ann Fam Med Date: 2005 May-Jun Impact factor: 5.166
Authors: Anthony A Cavallerano; Jerry D Cavallerano; Paula Katalinic; Beatrice Blake; Michael Rynne; Paul R Conlin; Kristen Hock; Ann Marie Tolson; Lloyd Paul Aiello; Lloyd M Aiello Journal: Am J Ophthalmol Date: 2005-04 Impact factor: 5.258
Authors: Yao Liu; Nicholas J Zupan; Olayinka O Shiyanbola; Rebecca Swearingen; Julia N Carlson; Nora A Jacobson; Jane E Mahoney; Ronald Klein; Timothy D Bjelland; Maureen A Smith Journal: PLoS One Date: 2018-11-02 Impact factor: 3.240